Your browser doesn't support javascript.
loading
A Comprehensive Algorithm for Management of Neuropathic Pain.
Bates, Daniel; Schultheis, B Carsten; Hanes, Michael C; Jolly, Suneil M; Chakravarthy, Krishnan V; Deer, Timothy R; Levy, Robert M; Hunter, Corey W.
Afiliación
  • Bates D; Metro Pain Group, Victoria, Australia.
  • Schultheis BC; Muskuloskelettales Zentrum - Interventionelle Schmerztherapie, Krankenhaus Neuwerk "Maria von den Aposteln," Mönchengladbach, Germany.
  • Hanes MC; Jax Spine & Pain Centers, Jacksonville, Florida.
  • Jolly SM; Louisiana Pain Specialists, New Orleans, Louisiana.
  • Chakravarthy KV; New Orleans East Hospital, New Orleans, Louisiana.
  • Deer TR; Department of Anesthesiology and Pain Medicine, University of California San Diego Health Sciences, La Jolla, California.
  • Levy RM; Veterans Administration San Diego Healthcare System, San Diego, California.
  • Hunter CW; The Spine and Nerve Center of the Virginias, Charleston, West Virginia.
Pain Med ; 20(Suppl 1): S2-S12, 2019 06 01.
Article en En | MEDLINE | ID: mdl-31152178
BACKGROUND: The objective of this review was to merge current treatment guidelines and best practice recommendations for management of neuropathic pain into a comprehensive algorithm for primary physicians. The algorithm covers assessment, multidisciplinary conservative care, nonopioid pharmacological management, interventional therapies, neurostimulation, low-dose opioid treatment, and targeted drug delivery therapy. METHODS: Available literature was identified through a search of the US National Library of Medicine's Medline database, PubMed.gov. References from identified published articles also were reviewed for relevant citations. RESULTS: The algorithm provides a comprehensive treatment pathway from assessment to the provision of first- through sixth-line therapies for primary care physicians. Clear indicators for progression of therapy from firstline to sixth-line are provided. Multidisciplinary conservative care and nonopioid medications (tricyclic antidepressants, serotonin norepinephrine reuptake inhibitors, gabapentanoids, topicals, and transdermal substances) are recommended as firstline therapy; combination therapy (firstline medications) and tramadol and tapentadol are recommended as secondline; serotonin-specific reuptake inhibitors/anticonvulsants/NMDA antagonists and interventional therapies as third-line; neurostimulation as a fourth-line treatment; low-dose opioids (no greater than 90 morphine equivalent units) are fifth-line; and finally, targeted drug delivery is the last-line therapy for patients with refractory pain. CONCLUSIONS: The presented treatment algorithm provides clear-cut tools for the assessment and treatment of neuropathic pain based on international guidelines, published data, and best practice recommendations. It defines the benefits and limitations of the current treatments at our disposal. Additionally, it provides an easy-to-follow visual guide of the recommended steps in the algorithm for primary care and family practitioners to utilize.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Algoritmos / Manejo del Dolor / Neuralgia Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Pain Med Asunto de la revista: NEUROLOGIA / PSICOFISIOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Algoritmos / Manejo del Dolor / Neuralgia Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Pain Med Asunto de la revista: NEUROLOGIA / PSICOFISIOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido